NMPA Approval

Latanoprost Eye Drops

Approval Number

国药准字HJ20171094

Registration Date

February 22, 2022

Previous Approval Numbers

H20171094

Drug Information

Generic Name

拉坦前列素滴眼液

Trade Name

适利达

Dosage Form

眼用制剂

Strength

0.005%（2.5ml: 125ug）

Drug Type

化学药品

Registration Date

February 22, 2022

Expiry Date

February 21, 2027

Company NameViatris GX

Company Address

Terhulpsesteenweg 6A, B-1560 Hoeilaart

Company Address

Rijksweg 12, 2870 Puurs-Sint-Amands, Belgium

Empowering clinical research with data-driven insights and AI-powered tools.

拉坦前列素滴眼液 - NMPA 批准文号 | MedPath